Federal health officials are preparing guidance on the rising risk of measles during pregnancy amid a significant surge in U.S. cases, but the release of key alerts and reports has faced internal delays at the Centers for Disease Control and Prevention (CDC). The growing outbreak has heightened concerns among clinicians, especially as many doctors today have limited experience managing measles in pregnant patients due to the disease’s prior rarity since its elimination in 2000.

In 2026, the United States has reported 4,852 measles cases, marking the highest total in 35 years. Pennsylvania alone accounts for nearly 1,400 cases, roughly one-third of the national count, including at least 77 diagnosed pregnant women since late April. The outbreak is concentrated in communities with lower vaccination rates, such as the Amish population, raising worries about underreporting.

Measles during pregnancy carries serious risks. It increases the likelihood of complications such as pneumonia and death in the mother, as well as miscarriage, premature birth, and low birth weight. Newborns can suffer from congenital measles, potentially resulting in encephalitis or death. However, some infected pregnant women may exhibit mild or no symptoms, complicating diagnosis and care. Premature infants born to vaccinated mothers may still remain vulnerable.

CDC scientists sought about a month ago to issue a rapid alert for clinicians through the agency’s Health Alert Network to address these concerns and provide updated clinical guidance. This network is typically used to quickly disseminate urgent public health information to physicians, laboratories, and health officials. According to sources familiar with the matter, the alert required approval from CDC leadership but was not authorized for reasons that remain unclear.

In response to the blocked alert, scientists pivoted toward preparing a detailed report for the CDC's Morbidity and Mortality Weekly Report (MMWR), the agency’s principal scientific publication. However, this report also encountered clearance delays amid the ongoing measles resurgence and has yet to be published.

Local health authorities have taken independent steps. Pennsylvania health officials issued a statewide alert urging immediate case reporting and vaccination before pregnancy, highlighting that the measles-mumps-rubella (MMR) vaccine cannot be administered during pregnancy. Due to privacy laws and the absence of a national tracking system specific to measles in pregnancy, the pregnancy outcomes of infected women remain largely unknown.

The CDC continues to track the outbreak and provide guidance, though a Department of Health and Human Services representative declined to comment on the reasons for withholding the earlier alert. The situation is complicated by political tensions between CDC leadership and Pennsylvania officials, particularly concerning the reporting of measles-related deaths.

Declining vaccination coverage is a key factor driving the outbreak. Current MMR vaccination rates fall below the 95 percent threshold needed for herd immunity. The Pan American Health Organization is scheduled to review the United States’ measles elimination status in November, with ongoing transmission now jeopardizing the country’s official standing.

The delays in publishing measles-related information mirror similar setbacks in releasing CDC reports on other vaccine-preventable diseases, such as pertussis, which has also seen recent case surges. Health officials emphasize the urgent need for timely dissemination of data and clinical guidance to manage these preventable diseases effectively.